Allarity Therapeutics, Inc. (ALLR): Nasdaq/NYSE listing notice — Allarity gets Nasdaq extension to April 10, 2023 to meet $2.5M equity requirement

Allarity Therapeutics, Inc.

Nasdaq granted extension until April 10, 2023, to regain compliance with $10M equity rule.
Company plan includes raising capital and moving to Nasdaq Capital Market ($2.5M equity).
Previous notice of deficiency received October 12, 2022; plan submitted December 12, 2022.
No assurance given that compliance will be achieved by the extended deadline.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

Allarity Therapeutics, Inc. received a nasdaq extension granted notice regarding stockholders equity (rules 5450(b)(1)(A)).

Exchange: nasdaq
Notice: extension granted
Deficiency: stockholders equity
Rules: 5450(b)(1)(A)

Exact text from the filing

December 21, 2022, the Company received notification from the Nasdaq staff that they have granted the Company an extension of time until April 10, 2023, to regain and evidence compliance with the Rule. No assurance can be given that the Company will be able to regain compliance with the Rule by April 10, 2023, as well as meet other notifications of deficiency subject to previous disclosure on Form 8-K (See Form 8-Ks filed with the SEC on November 25, and December 20, 2022). 1 SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this rep

View on SEC.gov

19 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

Allarity Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001213900-22-082358

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.